Insite Vision Inc (INSV) Return on Investment ROI from the second quarter of 2015 to second quarter of 2014 and for the year 2015, average high and low, overall ranking from Jun 30 2015 to Jun 30 2014 - CSIMarket
CSIMarket
 


Insite Vision Inc  (INSV)


Insite Vision Inc's ROI from its second quarter of 2015 to the second quarter of 2014 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Insite Vision Inc's ROI in the second quarter of 2015?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Insite Vision Inc's return on investment (ROI) in its second quarter of 2015

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2015)
II. Quarter
(Mar 31 2015)
I. Quarter
(Dec 31 2014)
IV. Quarter
(Sep 30 2014)
III. Quarter
(Jun 30 2014)
II. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - 912.64 % 247.46 % 90.61 % 131.56 %
Investment (TTM) in Millions -13 -6 -6 -3 0
Return On Investment (TTM) - - - - -
INSV's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - 14.39 % 10.59 % -13.75 % 828.08 %
Net Income (TTM) in Millions -13 31 27 24 28




Return On Investment INSV's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Insite Vision Inc's II. Quarter Investments $ -13 Millions INSV's Balance sheet
Insite Vision Inc's II. Quarter Income $ -7 Millions Quarterly INSV's Income Statement
INSV's Income by Division See INSV's Income by Division


INSV Annual Return On Investment (Dec 31 2014)
2014
(Dec 31 2013)
2013
(Dec 31 2012)
2012
(Dec 31 2009)
2011

Total Investments in Millions -6 -34 0 18 0
Y / Y Investment Growth - - - - -
Net Income in Millions 27 6 -8 -14 0
Y / Y Net Income Growth 362.91 % - - - -
Annual Return On Investment - - - -79.61 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
INSV's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for INSV's Competitors
Subscribers only: Roi for Insite Vision Inc's Suppliers
Subscribers only: Return On Investment for INSV's Customers

Other Ratios
INSV's Roa INSV's Inventory Turnover Ratio INSV's Growth Rates INSV's Dividend Statistics
INSV's Profitability Ratios INSV's Asset Turnover Ratio INSV's Dividend Growth
INSV's Roe INSV's Valuation Ratios INSV's Financial Strength Ratios INSV's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2015, within Healthcare Sector ROI
Dariohealth Corp   248.29 %
Cba Florida Inc   244.94 %
Adm Tronics Unlimited Inc   239.19 %
Orgenesis Inc   209.50 %
Elite Pharmaceuticals Inc   127.86 %
Armata Pharmaceuticals Inc   95.16 %
Viskase Holdings inc   85.03 %
Proteo Inc  69.41 %
Lumos Pharma Inc   61.69 %
Enveric Biosciences Inc   55.59 %
Gilead Sciences Inc   54.60 %
Abiomed Inc   49.09 %
Pacific Health Care Organization Inc  40.34 %
Brainstorm Cell Therapeutics inc   38.44 %


Date modified: 2026-08-29T17:23:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.